Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors.

The British journal of radiology·2026

Same author

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Current oncology (Toronto, Ont.)·2026

Same author

Seroprevalence of TORCH Infections among high-risk pregnant women, Datia, Madhya Pradesh.

Bioinformation·2026

Same author

Impact of Surgical Margins in Chest Wall Chondrosarcomas: A CanSaRCC Study.

Journal of surgical oncology·2026

Same author

Outcomes of Post-Traumatic Pediatric Endophthalmitis Following 25-Gauge Pars Plana Vitrectomy.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2026

Same author

Preoperative Radiotherapy and Postoperative Complications Among Patients with Primary Retroperitoneal Sarcoma: A Post Hoc Analysis of the EORTC-62092 (STRASS) Phase 3 Randomized Clinical Trial.

Annals of surgery·2026

Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026

Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026

Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 22, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Randomized Controlled Trials in Soft Tissue Sarcoma: We Are Getting There!

Andrea J MacNeill¹, Abha Gupta², Carol J Swallow³

¹Division of Surgical Oncology, Department of Surgery, Diamond Health Care Centre, BC Cancer Agency, University of British Columbia, 5199-2775 Laurel Street, Vancouver, British Columbia V5Z 1M9, Canada.

Surgical Oncology Clinics of North America

|September 20, 2017

Summary

This summary is machine-generated.

Soft tissue sarcoma (STS) management is complex due to limited evidence. Radiotherapy (RT) aids surgery and local control, with preoperative RT reducing chronic issues but increasing short-term wound complications. Systemic therapies

Keywords:

Chemotherapy Extremity sarcoma Preoperative radiotherapy Randomized controlled trial Retroperitoneal sarcoma Soft tissue sarcoma

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Feb 22, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

Oncology
Surgical Oncology
Radiation Oncology

Background:

Soft tissue sarcoma (STS) presents management complexities due to its rarity and heterogeneity.
Limited level 1 evidence challenges the design of robust clinical trials for STS.
Radiotherapy (RT) is a standard treatment modality in STS management.

Purpose of the Study:

To review the current evidence and clinical considerations for managing soft tissue sarcoma.
To discuss the role and timing of radiotherapy in relation to surgery for STS.
To examine the controversial role of adjuvant systemic therapies in adult STS.

Main Methods:

Literature review of existing studies on soft tissue sarcoma treatment.
Analysis of the benefits and risks of preoperative versus postoperative radiotherapy.
Discussion of systemic therapy options and their current evidence base.

Main Results:

Preoperative radiotherapy can reduce chronic toxicities associated with STS treatment.
Short-term wound complications may increase with preoperative radiotherapy.
The efficacy and necessity of adjuvant systemic therapies in adult STS remain debated.

Conclusions:

Treatment decisions for soft tissue sarcoma require careful consideration of individual patient factors and treatment modalities.
Radiotherapy plays a crucial role in function-preserving surgery and local control of STS.
Further research is needed to clarify the role of adjuvant systemic therapies in adult STS management.